Literature DB >> 8919186

Serial change of mitral regurgitation after mitral valve repair: comparison of anterior with posterior leaflet lesions.

T Fukui1, K Yoshida, T Akasaka, T Hozumi, Y Yamaura, C Izumi, Y Okada, T Shomura, J Yoshikawa.   

Abstract

Mitral valve repair is an important operative procedure for correcting mitral regurgitation (MR). However, serial change of residual MR after operation has not been reported. Serial change of MR after mitral valve repair was evaluated by transesophageal color Doppler echocardiography (TEE). Twenty-six patients undergoing mitral valve repair for MR during 1987 to 1991 were examined by TEE just after operation, 6 months after operation, and late follow-up period (mean 3.7 years). Thirteen patients had a lesion of the anterior mitral leaflet before operation (group A). Thirteen patients had a lesion of the posterior mitral leaflet before operation (group P). The MR area was measured by TEE at each stage after operation. In group A, the MR area at late follow-up increased significantly compared with just after operation (1.1 vs 4.3 cm2, p < 0.001). In group P, the MR area at late follow-up did not increase significantly compared with just after operation (0.6 vs 1.3 cm2, p = NS). In conclusion, MR does not increase after mitral valve repair in patients with posterior mitral valve repair, but MR may increase at late follow-up after operation for anterior mitral valve prolapse.

Entities:  

Mesh:

Year:  1996        PMID: 8919186

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  1 in total

1.  Influence of involvement of anterior leaflet versus posterior leaflet on residual regurgitation as assessed by transesophageal echocardiography in patients undergoing valve repair for mitral regurgitation due to mitral valve prolapse.

Authors:  Laureta Sulcaj; Antonio Rizza; Mattia Glauber; Giuseppe Trianni; Cataldo Palmieri; Marcello Ravani; Alban Dibra; Stefano Maffei; Sergio Berti
Journal:  Cardiovasc Ultrasound       Date:  2009-11-17       Impact factor: 2.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.